Patents deal pushes up cost of drugs
A DEAL between the government and the pharmaceutical industry is costing Australia hundreds of millions of dollars in drug subsidies, a leading health economist has calculated.
One cholesterol drug, atorvastatin, will cost the Australian health system $590 million more than New Zealand will pay for a generic alternative because of the memorandum of understanding signed between Medicines Australia and the government.
In that deal the government committed to an 18-month period to analyse and negotiate cuts to the amount it pays for drugs that come off patent. Sydney Morning Herald – Read more…